These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6299964)

  • 1. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.
    Donohue-Rolfe A; Keusch GT
    Infect Immun; 1983 Jan; 39(1):270-4. PubMed ID: 6295958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
    O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM
    Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae.
    Cruz JR; Cano F; Razin E; Acheson DW; Keusch GT
    J Pediatr Gastroenterol Nutr; 1995 Feb; 20(2):179-83. PubMed ID: 7714683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for shigella toxin.
    Donohue-Rolfe A; Kelley MA; Bennish M; Keusch GT
    J Clin Microbiol; 1986 Jul; 24(1):65-8. PubMed ID: 3522627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between production of cytotoxin and clinical features in shigellosis.
    Prado D; Cleary TG; Pickering LK; Ericsson CD; Bartlett AV; DuPont HL; Johnson PC
    J Infect Dis; 1986 Jul; 154(1):149-55. PubMed ID: 3519788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin--an expanding role in the pathogenesis of infectious diseases.
    Cantey JR
    J Infect Dis; 1985 May; 151(5):766-71. PubMed ID: 3886803
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of Shiga toxin by membrane vesicles in Shigella dysenteriae serotype 1 strains and in vitro effects of antimicrobials on toxin production and release.
    Dutta S; Iida K; Takade A; Meno Y; Nair GB; Yoshida S
    Microbiol Immunol; 2004; 48(12):965-9. PubMed ID: 15611613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA probes to identify Shiga-like toxin I- and II-producing enteric bacterial pathogens isolated from patients with diarrhea in Thailand.
    Seriwatana J; Brown JE; Echeverria P; Taylor DN; Suthienkul O; Newland J
    J Clin Microbiol; 1988 Aug; 26(8):1614-5. PubMed ID: 3049664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolabelling of Shiga toxin in macrophages infected with Shigella dysenteriae 1.
    Dacosta B; Sansonetti P; Ryter A
    Res Microbiol; 1990 Jun; 141(5):543-9. PubMed ID: 2218059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of monoclonal antibodies to Shiga toxin.
    Griffin DE; Gentry MK; Brown JE
    Infect Immun; 1983 Jul; 41(1):430-3. PubMed ID: 6345399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Shiga toxin 1 genes within Shigella dysenteriae type 4 isolates from travelers returning from the Island of Hispañola.
    Gupta SK; Strockbine N; Omondi M; Hise K; Fair MA; Mintz E
    Am J Trop Med Hyg; 2007 Jun; 76(6):1163-5. PubMed ID: 17556630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins.
    Kongmuang U; Honda T; Miwatani T
    J Clin Microbiol; 1987 Jan; 25(1):115-8. PubMed ID: 3539985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological detection assays for recombinant Shiga toxin &
    Gupta P; Dhaked RK
    Indian J Med Res; 2019 Mar; 149(3):412-417. PubMed ID: 31249208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1.
    McDonough MA; Butterton JR
    Mol Microbiol; 1999 Dec; 34(5):1058-69. PubMed ID: 10594830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.